Drug Screening Market Analysis

  • Report ID: 4891
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Drug Screening Market Analysis

End user – (Workplace, Hospital, Criminal Justice)

In the year 2037, the hospital segment is predicted to hold approximately 35% share of the drug screening market. The presence of a high number of patients in hospitals, which is rapidly expanding, can be attributed to the segment's expansion. Also, the hospitals are also growing rapidly in number. Hospitals provide a wide range of medical care in the form of physicians, called hospital doctors, who typically specialize in internal medicine, pediatrics, or general practice. They have better knowledge to figure out simple problems and also have the resources to solve unique medical problems. Hospitals may also offer specialized care, such as neurology, obstetrics and gynecology, and oncology.

Product Type: (Consumables, Instruments, Rapid Testing Devices, Services)

Rapid testing devices are projected to account for nearly 30% of the drug screening market share by 2037. The growing need for drug screening can be attributed to the segment's rise. The demand for drug screening is increasing across various industries, including healthcare, sports, and government agencies. Rapid testing devices provide a quick and easy way to screen individuals for drugs, making them an attractive option for these industries. In addition, these devices have undergone significant technological advancements in recent years, resulting in improved accuracy and sensitivity. These advancements have made rapid testing devices a more reliable and effective option for drug screening.

Our in-depth analysis of the global market includes the following segments:

 

        By End User

  • Workplace

  • Hospital

  • Criminal Justice

          By Product Type

  • Consumables

  • Instruments

  • Rapid Testing Devices

  • Services

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4891
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of drug screening is estimated at USD 11.57 billion.

The drug screening market size was over USD 9.99 billion in 2024 and is projected to cross USD 105.01 billion by the end of 2037, growing at more than 19.6% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of drug abuse, and stringent government regulations will boost the market growth.

Asia Pacific industry is set to hold 24% of the revenue share till 2037, impelled by rising awareness about drug screening in the region.

The major players in the market include Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), Thermo Fisher Scientific, Alere Inc., Siemens Healthineers, Shimadzu Corporation, F. Hoffmann-La Roche AG, Express Diagnostics International Inc., OraSure Technologies, Drägerwerk AG & Co. KGaA.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample